secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lexaria Bioscience Corp. (LEXX)
CIK:        0001348362
Form:       8-K
Filed at:   2023-11-03T23:59:59+00:00
Accession:  0001640334-23-002017
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Lexaria Bioscience regains Nasdaq bid price compliance; warrant exercises yield $444,895
--------------------------------------------------------------------------------

- Received Nasdaq letter on Nov 3, 2023 confirming cure of $1.00 minimum bid price deficiency after 11 consecutive days above $1.00 (Oct 19 - Nov 2).
- Since Oct 24, 2023, exercised warrants for 468,279 shares at $0.95/share, generating gross proceeds of $444,865.
- Pre-funded warrants exercised for 303,058 shares at $0.0001/share, generating gross proceeds of $30.31.
- Total common shares outstanding after these exercises: 9,752,259.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1348362/000164033423002017/0001640334-23-002017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1348362/000164033423002017/lxrp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-23-002017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer